Table 2.
N | Liver abscess | % (95% CI) | Spleen abscess | % (95% CI) | All | % (95% CI) | |
---|---|---|---|---|---|---|---|
Retrospective* | |||||||
Reference15 | 905 | 14 | 1.5 (0.8–2.5) | 2 | 0.2 (0.02–0.7) | 16 | 1.7 (1.0–2.8) |
Reference2 | 530 | 1 | 0.2 (0.01–1.0) | 0 | 0 (0–0.7) | 1 | 0.2 (0.01–1.0) |
Sub-Total | 1,435 | 15 | 1.0 (0.6–1.7) | 2 | 0.1 (0.01–0.5) | 17 | 1.2 (0.7–1.8) |
Prospective clinical† | |||||||
Reference17 | 709 | 4 | 0.6 (0.14–1.5) | 3 | 0.4 (0.09–1.2) | 7 | 1.0 (0.4–2.0) |
Prospective screening‡ | |||||||
Reference21 | 80 | 2 | 2.5 (0.3–8.7) | 1 | 1.3 (0.03–6.7) | 3 | 3.8 (0.8–10.6) |
Reference22 | 251 | 0 | 0 (0–1.4) | 4 | 1.6 (0.4–4.0) | 4 | 1.6 (0.4–4.0) |
Sub-Total | 331 | 2 | 0.6 (0.1–2.1) | 5 | 1.5 (0.5–3.5) | 7 | 2.1 (0.9–4.3) |
Total | 2,475 | 21 | 0.8 (0.5–1.3) | 10 | 0.4 (0.2–0.7) | 31 | 1.2 (0.8–1.8) |
CI = confidence interval.
Review of patient's files after discharge.
Patients prospectively screened clinically for signs and symptoms of liver/spleen abscess at the time of diagnosis of brucellosis then imaged.
Patients prospectively screened by ultrasound at the time of diagnosis of brucellosis.